da Vinci Xi Surgical System (IS4000);da Vinci X Surgical System (IS4200)
Intuitive Surgical, Inc. · Decision date Oct 30, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision for K263592 on October 30, 2026, covering the da Vinci Xi Surgical System (IS4000) and da Vinci X Surgical System (IS4200) from Intuitive Surgical, Inc. The submission was a Special 510(k) under 21 CFR 876.1500, product code NAY, received September 30, 2026. The summary describes the change as a software modification adding an insertion axis ball screw health check to the existing Power-On Self-Test algorithm; the predicate cited is K240852.
Intended use and indications are stated as unchanged from the predicate, and the summary reports software verification at unit, integration and system level. SESE is a 510(k) clearance, not a PMA approval. The documents do not quantify the effect of the added check on device performance or describe clinical testing, and no independent review was recorded.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Gastroenterology, Urology
- Decision date
- Oct 30, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K263592
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Intuitive Surgical, Inc.
- Product code
- NAY
- Decision code
- SESE
- Decision date
- Oct 30, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: System, Surgical, Computer Controlled Instrument.
- Applicant
- Intuitive Surgical, Inc.
- Product code
- NAY
- FDA device class
- 2
FDA decision timeline
K263592 received
Application receipt date recorded by FDA.
K263592 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code NAY
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Intuitive Surgical, Inc. | 510(k) clearance | Sep 8, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Intuitive Surgical, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Sunnyvale, CA
Sources and methodology
- Original FDA record: K263592
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records